4-amino-5-i1~iic1:rzo1cc:irbos:i1~iicIc
Erythrocytes, obtainetl fro111 a norrnal adult ~n a l e ancl fro111 a patient with Lesch-Nyhan syntlrorne, were incubated rrith 18-"Clatlenine antl [ 8 -1 . 1 C ] h y~) o~a~~t l~i~~e ('Fable 1). The 1al)eletl atlenine was utilizetl to about the same extent for the synthesis of ARII' by the nor~nal sol)ject's nncl the patient's erythrocytes. I)ea~l~ination of AbIP to IRlP occurred to about the same extent in both sa~nples. In contrast, hyposanthine was utilized cstensively for I h l P synthesis in the n o r r~~a l erythrocyte only. The a n~o o n t of total label in the IRlP was about 100 tirlles that of the sylpyrophosphate (PRPP) in the pathway regulation. The findings presented also offer a possil)le thcr:ipcutic approach to the early treatn~ent of the disease in the afflicted neonate. 'Fhe adn~inistration of AICA and/or rAICA, possibly s~~p p l e~l~e n t e d wit11 folic acid and allopurinol, by provitling a route to IhlI' and GXII', with or without concomitant recluction of the clevatecl I'RPP levels, 111ig11t eliminate, delay, or reduce t l~e clcvclop~nent of the s y~n p t o n~s and ~nanifestations of the genetic disease. Sveculation Lesch-Nyhan erythrocyte, a consequence of the cleficiency 'of hypoxanthine-gua~~ine phosphoribosyItMnsfer3se (IIGPRT) activity in t l~c synclron~e. No significant labeling of the A M P occurrctl. When alicluots of erythrocytes from both sources were incubated with 4-an1ino-5-ir11iclazoIecarboxa111idc (AICA) and sodiun~ ['"Cor~nate, cxter~sive labeling of the 1311' occurred in nornlal ancl in Lesch-Nyhan erythrocytes. The data suggest that AICA serves as a substrate for tlle adenine phosphoribosyltransferasc (APRT) of the Lesch-Nyhan erythrocyte and that the ribotide of AICA, 5'-phosphoribosyI-5-minoi111idazole-4-carboxarnide (AXCAR), undergoes formylation by labeled N1"-forrl~yl tetrahydrofolic acid formed fro111 the reaction of sodiunl [14C]forrnate with the tetrahydrofolic acid of the cell. The forrnyl-AICAR undergoes ring closure to IXIP by a series of reactions conlparable to those described for the nor~nal erythrocyte. When 5-a111ino-l-ribos~-4-irnidazoIecarboxan1ide (rAICA) and sodiu~n ['"Cjforn~ate were incubated with erythrocyte suspensions, extensive utilization for IMP synthesis was also observed in normal erythrocytes and in erythrocytes from LeschNyhan patients (Table 2) . Tlle reaction sequence is sonlewhat different from that of AICA. rAICA is not a substrate for the purine nucleosicle phosphorjlase of rabbit or h u n~a n erythrocytes. 'The ~nechanisnl of rAICA utilization is visualized as n direct phosphorglation of the ribosyl co~npound, p.ossibly by tlie adenosine kinase of the hurnan cell. The ribot~de, AICAR, forrlled by this r~~echanism, undergoes formylation and ring closure, yieltling IRIP. The gluta~lline antagonist, cliazooxonorleucine (DON), was added to alicluots of patients' cells incubated with rAICA and sotliunl ["C]for~nate. D O N is an effective inhibitor of the conversion of IMP to GRlP and its presence in an incubation suspension resulted in a soniewhat greater radioactivity of the total cellular IMP.
The extension of tlic current studies to Lcsch-Nghan cells in culture may scrve to assist in the direct evaluation of the regulatory role of IhIP in the d e rrovo pathway of purine nucleotide biosynthesis. Because of the substrate requirerlients of the rcnctions, the r~letabolis~li of AICA and rAICA nlay also serve to differentiate the roles of purine nucleotidcs ancl of phosphoriboThe erythrocytes of patients with Lesch-Nyhan synclro~ne, although lacking the e n~y m i c capacity for conversion of the 6-ketoporines, hyposantl~ine ancl guanine, to the corresponcling ribonucleoticles, can convert AICA and its ribosjl clcrivative (rA1CA) to II\II' by two clifferent reaction ~nechanisms, thus bypassing the enzgrnic tleficiency. The pathways clcscribed should be applicable to studies of regulatory n~echanisms in ile trotlo purine nucleotitle syntl~esis and in purine nucleotide interconversions. The irnidaz;le compounds 1;1ay also have therapeutic application in the early clinical treatn~er~t of the synclroole.
The Lesch-Nyhan syndrorne is chrrractcrized by mental retardation, chorcoathetosis, aggressive personality, and a bizarre urge for self-mutilation (8) . The X-linked recessive disorder has been associated with the inactivity of a specific enzyme of purinc mctabolisnl (23) . The cleficient cnzymc, HGPRT, is primarily responsible in normal cclls for rcutilization of the 6-ketopurines, I~ypoxarithirlc and guanine, which are rlerivcd from the breakdown of purine-containing compounds. Since the resultant nuclcotidcs, inosinc 5'-phosphate and guanosinc 5'-phosphate, serve as allostcric regulators of the initial enzyme of the tie rrovo path\vny of purine nuclcotidc biosynthesis, glutamine phosphoribosylpyropliosphate aniidotransferasc, the tleficiency may account, in part, for the overproduction of purine nuclcoticles tle rlovo as a characteristic property of the Lesch-Nyhan syntlromc (26). The failure to reutilize the purinc brrscs, a consequence of the enzymic deficiency, results in the extensive oxiclative metabolism of hypoxanthinc and guanine and a p r o n o u~~c e d hyperuricemia and hypcruricosuria. It also results in elcv;rted cellular lcvcls of PRPP, the other substrate of the HGPRT reaction (18).
Although there is no significant source of free adenine in humans, thc enzyme A P R T is present in normal human and Lesch-Nyhan cells ant1 can effect the formation of A M P from administered adenine. The AhlP, a regulator of the initial enzyme, could be converted, in part, to IMI' and GMP. However, the administration of largc amounts of adenine can lead to clcpositiorl of 2,8-cliosyaclcrii1ic ill the kidneys aritl a resultant irnp;~irrncnt of rcri;~l furletion (70). Nevcrtliclcss. in all attempt to cr~h;~ricc tlic level of all allosteric regul;~tor of glut;~minc pl1osplloril>osy11>yropI1osphatc arnidotransfcrasc. arid perhaps to reverse the pl~ysical rnarlifcstations of the synclromc, scvcr;~l investigators Iiavc arlrniriistcrerl to patients the puriric base. aileninc, ;~lonc o r in corijunction with folic acid ;~n~l allopuririol ( I , 70, 21).
I t Ii;~s hecn clcriioristr;~tecl in this laboratory t l i ;~t the norrn;\l human erytlirocytc lacks the cap;~city for the hiosyr~tliesis of tlie purine nucleotidcs by tlic o\,crall tlc rroifo patlitvay. Yet the cell c:ln carry out tllc final reactions of tlie patli\vay (13) . utilizing AICA o r r A l C A ;IS precursors of tlie nucleotiile internicrliate, AICA R . 7'Iius. AICA I l , forriiccl either hy phospIioryl;~tiori of rAlCA o r by a ~>I~osplioribosyltrarisfer~~sc-c;~t;iIyzcd rc;~ction of AICA ;rntl I'llPI', can unclcrgo formylation 2nd ring closurc to yield IhlP iri rc:~ctions that clo not rccluirc tllc intact tic rro~w pathway of puriric nuclcoti(lc syntllcsis (Fig. I ) .
Since thcsc rc;~ctions coulcl serve to bypass tlic 11GPR71' dcficicncy in the cclls of a Lcscli-Nylian p;~ticrit, this stucly \\as undertaken to clctcrminc the ci~pacity of the Lcsch-Nyh;~n crytlirocytc to utilize AICA o r r A l C A for the forniation of IhlI' in the ;~bscnce of 11GPR.I' activity. Control blood samples \\ere dr;~\vn from a normal aclult male. All blood s;~riiplcs had been obtained in ;~ccord with the 1)cclaration of 13clsir1ki. Whole blood s;lniplcs, collcctccl in hep;~rin, u c r c ccntrifugcd. Pl;lsnia nncl huffy coat wcrc rcmovccl. W;~shc(l intact erythrocytes were iricirh;~tcJ \\.it11 appropriate substrates at 37" for 2 hr. At the encl of the incubation period. the intact erythrocytes were ccntrifugccl anel \vaslic(l tlircc timcs tvith isotonic si~linc solution. Tlic \vasliecl cclls wcrc extracted lvitli colcl 8 % pcrchloric acicl. l'lic extracts wcrc centrifuged and tlie 511-pernatant solutions wcrc ncutralizccl with 5 hl K,CO:l. After cooling, the potassium pcrclilorate precipitates were removccl by centrifugation. Carrier lhlP (0.12 pmol in 20 pl solution) ant1 aliquots of c;~cli cxtr;ict (00 PI) \\'ere applied in 5 PI aliquots, to sclu:lrcs (2.25 ~111~) of clietllyl;~riiirioctliyl (1lIiAIZ)-cellulose paper (\Vliatn~;~n I > l 3 l ) . The I>EAI:.-paper l>irlcls ~iuclcoticles.
.' ' ,~crlrt;~ting the rcriiov;~l of frcc puriries. riuclcosidcs. ;~ncl cxccss socliirm I 'Cjformatc.
1:ach Jriccl scluare was \v;~slicd using the nictliocl of Silvers cp/ 111. (24) . and then sewn o n to a polyetllylcnciminc (PE1)-ccllulose thin layer clirorllatograpIlic plate (Urinkm;~nn Instruments, Iric.). Chrornatograpliy \\:is carriecl out in 5 0 rnl 0.5 hl LiCI, ;~rlcl 5 0 rnl 2 hl formic ;~cicl.
Compoun(ls or1 tlic rlriccl plate were irlcr~tificcl ;lncl clutccl froail tllc scraped ccllulosc po\vclcr \\ith 0.1 N IICI. 71'lic itlcntitics \\ere verified spcctropliotoriictri~~lly. Aliquots ( 0 . I rill) o f t .~ eluates were :~ss;~yed for radioactivity in ;I 1';lckarJ scintillatior1 counter. D;I~;I arc csprcsscd ;IS c;~lculatcd tot;rl raclioactivity of the nucleoti(lc per ml crythrocytc.
I~rythrocytcs, obtaineel f r o n~ a riormal ;~dult rn;~le anrl those obti~inccl fro111 n patient with Lcscll-Nyh;~ri syritlronic \vcrc incuhated \vitli [X-"Clarleninc ancl [S-It Cjliypox;~ntliir~c (71';~171e 1). The labeled acleniric \\as utilizeel to about the sanic extent for the syntlicsis of A h l P by the norni;ll ant1 the patierit's erythrocytes. Ilc;~miri;~tior~ of A h l P to Ihll' occurrecl to ;thout tlie s;rmc extent in hoth s;~mples. l'he form;~tion o f Ahll' is in accorcl \villi the knotvri prescricc of ;~r i active AI'RI' in norrlial and Lcsch-Nyhan erythrocytes. In contrast. hypos;~rithine was utilizccl cstcnsivcly for Ihll' syntlicsis in the riorrn;~l crythrocytc only. Tlic ;~m o u r~t of total lal>el in the IhlI' \\.;IS ;~l>out 100 timcs that of tlic LcscliNyli;~n erythrocyte. ;I conscclucncc of the tlcficicncy of IICPR'I' :~ctivity i l l t l~c \.11iIro1ne. N o hig~lil'ic:~~lt lal>cli~~g of t l~c Ahll' occurred.
When ;~licluots of erytliroctcs from hoth sources Iverc incuIx~tcd with 4-aniino-5-ir~iicI;1zoIcc;1rI~os;1riicIc and sotliuri~ [l1C]form;~tc, cxterisive I:~l>cling of tlic IhlI' occurrccl in normal ;~ncl in Lcscli-Ny1i;rn crythrocytcs. 71'he data suggest th;~t A I C A serves ;IS ;I substrate for the Al'I7T of the Lcsch-Nylian erythrocyte ancl that the rihoticlc of A I C A (AICAII) unclergocs formylt~tiori by labeled N1"-formyl tctraliyclrofolic acid fornicd from the reaction of soclium ["C]formatc with tlic tctr;~liytlrofolic ;~cirl of tlic cell. Tlic forniyl-AICAIl untlcrgocs ring closure to Ihll' by ;I scrics of re;~ctioris conipar;~blc to those Jcscribcd for tlie riormal erythrocyte.
The ;~l>sencc of appreciable I;tbcl in the A h l P obtaineel from the hy~x)x;~r~tliinc and AICA cxpcrimcnts suggests th;rt the Lcsch-Nylian erytl~rocytc ;~n(l the riormal huriian crythrocytc rcscmblc each other in tlicir in;~bility to convert Ihll' to Ahll' (1 3), a rcs~rlt of the ;~bseriee of ;~cIc~~yI~i~eciri;LtC s y~i t I i c t ;~~c ~~c l i vity ( 10).
.l'lic finding that AICA ;~ricl socliunl [ l l C ] f o r n~a t c were utilizeel for Ihll' syntlicsis in the Lescli-Nylian erythrocyte was cxtcncle(l to the erythrocytes of two acldition;~l paticnts (T;~hlc 7 ) . Althoirgll the extent of 1;tbcling of the lhlP was somc\vh;~t vari:~hlc. Aliquots of \vashcd (rytlirocytcs (0.85 nil) were incubated for 2 hr at 37" in cclual volurncs of isotonic sodium phosphate buffer (pll 7.4) containing glucose (15 pmol). Carrier IhlP was addcd. Nucleo.iclcs were isolated, purified, and assayc~l for radioactivity. of label in the latter IhfP fractions arc basecl on values only slightly above backgrouncl radioactivity anti coulcl be attrihutccl to the small number of rcticulocytcs in the preparz~tion.
When rAICA and soclium I1'C]formatc were incubated wit11 .
erythrocyte suspensions, extensive utilization for IMP synthesis was also observed in normal erythrocytes ancl in erythrocytes from Lesch-Nyhan patients. The reaction sccjucncc is somewhat clifferent from that of AICA. rAICA is not a substrate for the purine nuclcoside phosphorylasc of rabbit or human crytlirocytcs ( 9 , 11) . The mechanism of rAICA utilization is visunlizcd as a clircct phosphorylation of tlie rihosyl compouncl, possible by the aclcnosinc kinasc of the human cell (17) . The riboticlc AI-C A R , formcd by this mechanism, unclergocs formylation ancl ring closure, yielding IMP. 'fhc glut;~minc antagonist, DON was aclclccl to aliquots of patients' cells incubatcrl with rAlCA and sodium [llC]formate. DON is an effective inhibitor of the convcrsion of IMP to G h l P (I I ) and its prescnce in an incubation suspension resulteel in a somewhat greater raclioactivity of the total cellular IhlP. This effect was also obscrvetl \\.hen erythrocytes from a normal adult male were incubated with AICA ancl soclium [14C]formatc in the presence and absence of DON.
Thc purine nuclcoticles of the percliloric acid extract from patient J A were hydrolyzctl and the raclioactivity of the purines urts dcterrninccl. No significant labeling of the isolated adenine was detected, even ill the presence of sufficient DON to inhibit the convcrsio~i of IMP to GMP. lIypoxantliinc, obtained frorn the labeled IMP, was appreciably labeled in accorcl with the data of Table 1 .
DISCUSSION
Despite the nurncrous studies that have bccn concerneel tvith the biocheniistry of the Lesch-Nyhan syndronic, the causal relationship between tlic enzymic cleficicncy ancl the behavioral rtncl physical ni;~nifcstations of the cliscase remains intriguing ant1 elusive. A number of interesting observations may be pertinent to its etiology. It has bccn found that, in the normal human, the major site of HGPRT activity is in the brain (19). The enzymic deficiency in the brain of the Lcsch-Nyhnn individual nncl a resultant incrcasecl activity of tlic rle rlovo pathway cc)uld lend to a diminution of brain gluta~nine or a related metabolite (4), since 2 molecules of the amino acid arc required for each molecule of I M P formed, and a third molecule is required for the convcrsion of IMP to GhIP. Furthermore, it has bccn reported that the activity of IMP dehytlrogcnase, an enzyme on tlie pathway to GhlP, is increased in Lesch-Nyhan patients (17) . The stimulation of tlc rrorlo synthesis, \vhicli coulcl be : I consequence of elevated PRPP levels (18). may also affect the cellular folates of all tissues (6, 15) . The low level o f glut;tniine phosphoribosylpyrophosphatc amidotransfcr:~se i l l m:tmrnalian brain suggests a dependence upon HGPRT for puri~ic nuclcotidc formation (5) .
The present stucly proviclcs experimental cviclencc for enzymic activities within the Lcsch-Nyhan erythrocyte that can leatl to a metabolic bypass of the I-1GPRT tlcficiency in the genetic cliscase. The presence of APRT and of a kinasc that can pliosphorylute rAICA serves to accomplish the synthesis of IhlP from enclogcnously supplied precursors. 'l'hc reactions li:~vc been summarized in Figure I .
'l'he first reaction secluence occurs hec;~usc AICA can serve as a substrate for the Al'li'l' o f normal and Lcsch-Nyhan crythrocytcs (25) . Since the compound is an inhibitor of fIGPRT (7), a rnorc effective utilization \voulcl not be expcctccl in the normal erythrocyte which contains both HGPRT ancl APR'T activities.
The scconcl reaction sequence is clepcntlcnt upon the presence o f a kinuse, possibly atlcnosinc kinasc (1 2). that can phosphorylate rAICA. The kinasc activity has previously been founcl in yeast. pigeon liver, and normal hunian ancl rabbit erythrocytes (2, 1 I , 13).
Since G b l P is readily formed in the Lcsch-Nyhan cell from IMP, the demonstration of a bypass mechanism for the formation of IMP in thc erythrocyte of the patient ;~lso implies ;I pathway to GMP, thereby overcoming tlic total clualitativc clcfeet of the cliseusc, \vitliout the i1ivoIve111e1it of the overall tic tror80 pathway and the problem of an overactive series of rcactions.
An cnha~icemcnt of IMP and GPvlP lcvcls in tlic Lesch-Nylinn cell and a direct study of their regulatory roles itr t~itro have not been unrlertrtkcn to elate, for a number of reasons. Exogenous ~iuclcotidcs, pcr se, cannot permeate the ccll nicrnbranc. Although purine bases and their nuclcosides enter the cell, convcrsion of the 6-kctopurines to the nucleoticlcs requires EIGPRT. Furtlicrriiorc, i r~ thc absence of an appreciable ability of mammalian cells to phospl~oryl:~tc inosinc ant1 gunnosine, the 6-kctopurine nucleosides arc not converted to the nuclcotidcs (3, 16).
The niamrnalian crythrocytc is unable to synthesize the purine nucleotidcs by the rlc trorvo biosynthctic pathway ancl hence tlic bypass mechanism demonstrated to exist within that ccll can not be applied to a study of the regulation of the tle trovo pathway in either the normal or Lcsch-Nyhan erythrocyte. However, the nicclianisrii is applicable to stuclics in other Lesch-Nyhan cclls and tissues in which tie t r o~~o purine nucleotirlc synthesis may be . . I he f i n d i n g s p r c s e t i t c d also o f f e r ;I possihlc t h c r a p c u t i c npproach t o t l i e e a r l y t r c i i t m c t i t of t h e discasc it1 t h e a f f l i c t e t l n e o n a t e . .l'hc a t 1 m i n i s t r ; l t i o n o f AICA a n d / o r r A I C A , possibly s u p p l c m e n t c d \vitli folic acid ;11itI nllopurinol, by p r o v i i l i n g n r o u t e t o l h l P an11 GRIP, tvitli o r \vitliout c o t i c o m i t a n t r e c l u e t i o n o f t h e e l c v n t c i l I'RPI' I c v c l s , m i g h t c l i n i i n a t c , d e l a y , o r r c t l u c c t h e t l c v c l o l , m e n t o f t h e s y m p t o m s a t i d m ; i n i f e s t a t i o n s o f t h e g e n e t i c d i s c a s c . S e v e r a l i n v e s t i g a t o r s h a v e s t u d i e d t h e m c t a b olistii and c s c r e t i o n o f t h e itiiiilazolc compounds in t h e normal l i u t i i a n . The s t u r l i c s suggest t h a t oral a d~i i i s t r a t i of the com- 
